Cargando...
A feasibility study of the Nativis Voyager(®) device in patients with recurrent glioblastoma in Australia
AIM: Evaluation of the Nativis Voyager(®), an investigational medical device, as monotherapy for recurrent glioblastoma (rGBM). MATERIALS & METHODS: A total of 15 patients with rGBM were treated with one of two Voyager ultra-low radio frequency energy cognates: A1A or A2HU. Safety and clinical u...
Guardado en:
| Publicado en: | CNS Oncol |
|---|---|
| Autores principales: | , , , , , |
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Future Medicine Ltd
2019
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6499017/ https://ncbi.nlm.nih.gov/pubmed/30727742 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2217/cns-2018-0017 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|